Hiroko Iwanari

2.1k total citations
31 papers, 1.7k citations indexed

About

Hiroko Iwanari is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Hiroko Iwanari has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Oncology. Recurrent topics in Hiroko Iwanari's work include Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Hiroko Iwanari is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Neuropeptides and Animal Physiology (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Hiroko Iwanari collaborates with scholars based in Japan, United States and United Kingdom. Hiroko Iwanari's co-authors include Takao Hamakubo, Tatsuhiko Kodama, Hiroyuki Aburatani, Junji Shibahara, Naoko Yamauchi, Masashi Fukayama, Yoshitaka Hippo, Toshiro Niki, Shuying Jiang and Riuko Ohashi and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Hiroko Iwanari

31 papers receiving 1.6k citations

Peers

Hiroko Iwanari
David A. Ruddy Switzerland
Jilin Sun United States
Tommy A. Brock United States
Hakjoo Lee United States
D. Kirk Ways United States
Albina Nesterova United States
Hiroko Iwanari
Citations per year, relative to Hiroko Iwanari Hiroko Iwanari (= 1×) peers Franca Codazzi

Countries citing papers authored by Hiroko Iwanari

Since Specialization
Citations

This map shows the geographic impact of Hiroko Iwanari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Iwanari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Iwanari more than expected).

Fields of papers citing papers by Hiroko Iwanari

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Iwanari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Iwanari. The network helps show where Hiroko Iwanari may publish in the future.

Co-authorship network of co-authors of Hiroko Iwanari

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Iwanari. A scholar is included among the top collaborators of Hiroko Iwanari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Iwanari. Hiroko Iwanari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimamura, Tatsuro, Masahiro Hayashi, Norimichi Nomura, et al.. (2023). Structure and mechanism of oxalate transporter OxlT in an oxalate-degrading bacterium in the gut microbiota. Nature Communications. 14(1). 1730–1730. 8 indexed citations
2.
Soda, K., et al.. (2020). AT2 receptor interacting protein 1 (ATIP1) mediates COX-2 induction by an AT2 receptor agonist in endothelial cells. Biochemistry and Biophysics Reports. 24. 100850–100850. 3 indexed citations
3.
Fujiwara, Kentaro, Atsushi B. Tsuji, Hiroko Iwanari, et al.. (2020). Single-Dose Cisplatin Pre-Treatment Enhances Efficacy of ROBO1-Targeted Radioimmunotherapy. International Journal of Molecular Sciences. 21(20). 7728–7728. 1 indexed citations
4.
Asada, Hidetsugu, Asuka Inoue, Francois Marie Ngako Kadji, et al.. (2019). The Crystal Structure of Angiotensin II Type 2 Receptor with Endogenous Peptide Hormone. Structure. 28(4). 418–425.e4. 41 indexed citations
5.
Asada, Hidetsugu, Shoichiro Horita, Kunio Hirata, et al.. (2018). Crystal structure of the human angiotensin II type 2 receptor bound to an angiotensin II analog. Nature Structural & Molecular Biology. 25(7). 570–576. 53 indexed citations
6.
Nagata, Nanae, Hiroko Iwanari, Hidetoshi Kumagai, et al.. (2017). Generation and characterization of an antagonistic monoclonal antibody against an extracellular domain of mouse DP2 (CRTH2/GPR44) receptors for prostaglandin D2. PLoS ONE. 12(4). e0175452–e0175452. 7 indexed citations
7.
Takemoto, Kiwamu, Hiroko Iwanari, Takeharu Nagai, Takao Hamakubo, & Takuya Takahashi. (2016). Optical inactivation of calcium-permeable AMPA receptors for artificial memory erasure. 1 indexed citations
8.
Inoue, Mayuko, Hidenori Tabata, Daijiro Konno, et al.. (2016). Prdm16 is crucial for progression of the multipolar phase during neural differentiation of the developing neocortex. Development. 144(3). 385–399. 40 indexed citations
9.
Kurosawa, Kazuhiro, Tatsuro Misu, Yoshiki Takai, et al.. (2015). Severely exacerbated neuromyelitis optica rat model with extensive astrocytopathy by high affinity anti-aquaporin-4 monoclonal antibody. Acta Neuropathologica Communications. 3(1). 82–82. 50 indexed citations
10.
Nomura, Yayoi, T. Arakawa, Tomoya Hino, et al.. (2014). Proteoliposome-based Selection of a Recombinant Antibody Fragment Against the Human M2 Muscarinic Acetylcholine Receptor. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 33(6). 378–385. 16 indexed citations
11.
Hino, Tomoya, T. Arakawa, Hiroko Iwanari, et al.. (2012). G-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody. Nature. 482(7384). 237–240. 239 indexed citations
12.
Minegishi, Yuriko, Hiroko Iwanari, Yasuhiro Mochizuki, et al.. (2009). Prominent expression of FRS2β protein in neural cells and its association with intracellular vesicles. FEBS Letters. 583(4). 807–814. 5 indexed citations
13.
Jiang, Shuying, Riuko Ohashi, A.S. Savchenko, et al.. (2009). Protein expression of nuclear receptors in human and murine tissues. Pathology International. 59(2). 61–72. 5 indexed citations
14.
Yoshitake, Hiroshi, Yasuhiro Mochizuki, Hiroko Iwanari, et al.. (2008). Molecular diversity of TEX101, a marker glycoprotein for germ cells monitored with monoclonal antibodies: Variety of the molecular characteristics according to subcellular localization within the mouse testis. Journal of Reproductive Immunology. 79(1). 1–11. 12 indexed citations
15.
Umezu, Hajime, Takashi Yamamoto, Shuying Jiang, et al.. (2008). Expression of hepatocyte nuclear factor 4α in primary ovarian mucinous tumors. Pathology International. 58(11). 681–686. 26 indexed citations
16.
Imamura, Masaru, Riuko Ohashi, Shuying Jiang, et al.. (2008). Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. The Journal of Pathology. 215(1). 48–55. 163 indexed citations
17.
Imamura, Masaru, Takashi Kawasaki, A.S. Savchenko, et al.. (2007). Lipopolysaccharide induced expression of pentraxin 3 in human neutrophils and monocyte-derived macrophages. Cellular Immunology. 248(2). 86–94. 35 indexed citations
18.
Oshima, Tomoko, Takashi Kawasaki, Riuko Ohashi, et al.. (2007). Downregulated P1 promoter‐driven hepatocyte nuclear factor‐4α expression in human colorectal carcinoma is a new prognostic factor against liver metastasis. Pathology International. 57(2). 82–90. 34 indexed citations
19.
Fukumoto, Shinichi, Naoko Yamauchi, Hisashi Moriguchi, et al.. (2005). Overexpression of the Aldo-Keto Reductase Family Protein AKR1B10 Is Highly Correlated with Smokers' Non–Small Cell Lung Carcinomas. Clinical Cancer Research. 11(5). 1776–1785. 250 indexed citations
20.
Jiang, Shuying, Toshiya Tanaka, Hiroko Iwanari, et al.. (2003). Expression and localization of P1 promoter-driven hepatocyte nuclear factor-4α (HNF4α) isoforms in human and rats. PubMed. 1(1). 5–5. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026